Electronic Health Record-Enabled Evidence-Based Smoking Cessation Quality Improvement Implementation Program
NCT ID: NCT04107857
Last Updated: 2024-12-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000000 participants
OBSERVATIONAL
2019-10-02
2024-10-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Smoking Cessation
* Patients enter the program through clinic appointments or community outreach programs.
* Patients will be given brief advice to quit smoking and referral options to receive evidence-based treatment through Missouri/Illinois Quitlines, Smokefree.TXT, or smokefree.gov dependent on the patient's preference for counseling
* Patient can also be prescribed smoking cessation pharmacotherapy
ELEVATE enhancement to electronic health record (EHR) to improve cessation counseling offer
* Brief advise to quit smoking
* Referral to Missouri/Illinois Quitlines, Smokefree.TXT, or smokefree.gov
ELEVATE enhancement to electronic health record (EHR) to improve smoking cessation medication offer
-Nicotine replacement therapy, varenicline, bupropion, or combination therapy (not provided by study)
Data Driven Feedback reports
-Feedback reports will be based on data
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ELEVATE enhancement to electronic health record (EHR) to improve cessation counseling offer
* Brief advise to quit smoking
* Referral to Missouri/Illinois Quitlines, Smokefree.TXT, or smokefree.gov
ELEVATE enhancement to electronic health record (EHR) to improve smoking cessation medication offer
-Nicotine replacement therapy, varenicline, bupropion, or combination therapy (not provided by study)
Data Driven Feedback reports
-Feedback reports will be based on data
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Washington University School of Medicine
OTHER
National Cancer Institute (NCI)
NIH
National Institutes of Health (NIH)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Li-Shiun Chen, M.D., ScD, MPH
Role: PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Washington University School of Medicine
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
89276
Identifier Type: -
Identifier Source: org_study_id